COMP <GO>
SNDL vs USNA // GROSS PROFIT MARGIN
SNDL Inc. (NASDAQ) VS. USANA Health Sciences Inc. (NYSE) • 15-METRIC TALLY: SNDL 2
— USNA 0
■ METRIC PARITY
LAST: $1.30 (+0.78%) • MKT CAP: $316.3M
gross-margins
—
LAST: $14.34 (-1.91%) • MKT CAP: $265.0M
gross-margins
78.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SNDL VS. USNA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SNDL | USNA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | 78.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 7.90% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 2.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 3.22% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | 4.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 1.20% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 8.30% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.56 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 7/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.4 | 45.8 | +7.60 | SNDL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 22.9x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $316.3M | $265.0M | $51.3M | SNDL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SNDL REV | USNA REV | SNDL GROSS % | USNA GROSS % | SNDL FCF | USNA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $925.3M | — | 78.3% | — | $8.5M |
| FY 2024 | — | $854.5M | — | 81.1% | — | $50.9M |
| FY 2023 | — | $921.0M | — | — | — | $70.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SNDL // BETA —
USNA // BETA —